Ceftriaxone Injection, Powder, For Solution
NDC Package 44567-702-25
Package Information
Ceftriaxone injection is ceftriaxone is used to treat a wide variety of bacterial infections. This formulation utilizes a injection, powder, for solution delivery system. Marketed by Wg Critical Care, Llc, this product is identified by NDC 44567-702 and is authorized under FDA application ANDA065329.
Identification & Billing
- RxCUI: 1665021 - cefTRIAXone 1 GM Injection
- RxCUI: 1665021 - ceftriaxone 1000 MG Injection
- RxCUI: 1665021 - ceftriaxone 1 GM (as ceftriaxone sodium) Injection
- RxCUI: 1665046 - cefTRIAXone 2 GM Injection
- RxCUI: 1665046 - ceftriaxone 2000 MG Injection
Clinical Specifications
- Intramuscular - Administration within a muscle.
- Intravenous - Administration within or into a vein or veins.
- Intramuscular - Administration within a muscle.
- Intravenous - Administration within or into a vein or veins.
Regulatory & Marketing
Hierarchy Structure
- 44567 - Wg Critical Care, Llc
- 44567-702 - Ceftriaxone
- 44567-702-25 - 25 VIAL in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
- 44567-702 - Ceftriaxone
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (44567-702). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44567-702-25 identifies a specific commercial package of 25 vial in 1 carton / 1 injection, powder, for solution in 1 vial of Ceftriaxone, a human prescription drug labeled by Wg Critical Care, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 25 billable units per package. This injection, powder, for solution is formulated for intramuscular; intravenous use and contains ceftriaxone sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Wg Critical Care, Llc on July 24, 2008. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Ceftriaxone is used to treat a wide variety of bacterial infections. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria. This drug is not recommended for use in newborns with high blood bilirubin levels and premature infants due to increased risk of side effects. Ask the doctor or pharmacist for details.
How is this Wg Critical Care, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44567070225. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 25 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
